Literature DB >> 25648834

Altered metabolism and resistance to obesity in long-lived mice producing reduced levels of IGF-I.

Adam B Salmon1, Chad Lerner2, Yuji Ikeno3, Susan M Motch Perrine4, Roger McCarter5, Christian Sell2.   

Abstract

The extension of lifespan due to reduced insulin-like growth factor 1 (IGF-I) signaling in mice has been proposed to be mediated through alterations in metabolism. Previously, we showed that mice homozygous for an insertion in the Igf1 allele have reduced levels of IGF-I, are smaller, and have an extension of maximum lifespan. Here, we tested whether this specific reduction of IGF-I alters glucose metabolism both on normal rodent chow and in response to high-fat feeding. We found that female IGF-I-deficient mice were lean on a standard rodent diet but paradoxically displayed an insulin-resistant phenotype. However, these mice gained significantly less weight than normal controls when placed on a high-fat diet. In control animals, insulin response was significantly impaired by high-fat feeding, whereas IGF-I-deficient mice showed a much smaller shift in insulin response after high-fat feeding. Gluconeogenesis was also elevated in the IGF-I-deficient mice relative to controls on both normal and high-fat diet. An analysis of metabolism and respiratory quotient over 24 h indicated that the IGF-I-deficient mice preferentially utilized fatty acids as an energy source when placed on a high-fat diet. These results indicate that reduction in the circulating and tissue IGF-I levels can produce a metabolic phenotype in female mice that increases peripheral insulin resistance but renders animals resistant to the deleterious effects of high-fat feeding.

Entities:  

Keywords:  gluconeogenesis; insulin; insulin-like growth factor I; metabolism; obesity

Mesh:

Substances:

Year:  2015        PMID: 25648834      PMCID: PMC4385875          DOI: 10.1152/ajpendo.00558.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  53 in total

1.  Metabolic effects of intra-abdominal fat in GHRKO mice.

Authors:  Michal M Masternak; Andrzej Bartke; Feiya Wang; Adam Spong; Adam Gesing; Yimin Fang; Adam B Salmon; Larry F Hughes; Teresa Liberati; Ravneet Boparai; John J Kopchick; Reyhan Westbrook
Journal:  Aging Cell       Date:  2011-11-28       Impact factor: 9.304

2.  Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.

Authors:  K Rajkumar; M Krsek; S T Dheen; L J Murphy
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

3.  Dysregulation of energy homeostasis in mice overexpressing insulin-like growth factor-binding protein 6 in the brain.

Authors:  G Bienvenu; D Seurin; Y Le Bouc; P Even; S Babajko; C Magnan
Journal:  Diabetologia       Date:  2005-05-12       Impact factor: 10.122

4.  Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile.

Authors:  T Quattrin; K Thrailkill; L Baker; J Litton; K Dwigun; M Rearson; M Poppenheimer; D Giltinan; N Gesundheit; P Martha
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

5.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

Authors:  F Lupu; J D Terwilliger; K Lee; G V Segre; A Efstratiadis
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

6.  Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.

Authors:  P A Crossey; J S Jones; J P Miell
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

7.  Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet.

Authors:  Cheryl A Conover; Sara L Harstad; Tamar Tchkonia; James L Kirkland
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-17       Impact factor: 4.310

8.  A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.

Authors:  Katie Robertson; Yarong Lu; Kristine De Jesus; Bing Li; Qing Su; P Kay Lund; Jun-Li Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-12       Impact factor: 4.310

9.  Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.

Authors:  Yong Fan; Ram K Menon; Pinchas Cohen; David Hwang; Thomas Clemens; Douglas J DiGirolamo; John J Kopchick; Derek Le Roith; Massimo Trucco; Mark A Sperling
Journal:  J Biol Chem       Date:  2009-05-21       Impact factor: 5.157

10.  Skeletal muscle growth hormone receptor signaling regulates basal, but not fasting-induced, lipid oxidation.

Authors:  Archana Vijayakumar; YingJie Wu; Nicholas J Buffin; Xiaosong Li; Hui Sun; Ronald E Gordon; Shoshana Yakar; Derek LeRoith
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

View more
  8 in total

1.  Rapamycin increases oxidative metabolism and enhances metabolic flexibility in human cardiac fibroblasts.

Authors:  Timothy Nacarelli; Ashley Azar; Oya Altinok; Zulfiya Orynbayeva; Christian Sell
Journal:  Geroscience       Date:  2018-06-21       Impact factor: 7.713

Review 2.  The somatotropic axis and aging: Benefits of endocrine defects.

Authors:  Andrzej Bartke; Edward O List; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2016-02-16       Impact factor: 2.372

Review 3.  Minireview: The Complexities of IGF/Insulin Signaling in Aging: Why Flies and Worms Are Not Humans.

Authors:  Christian Sell
Journal:  Mol Endocrinol       Date:  2015-06-23

Review 4.  Biochemical Genetic Pathways that Modulate Aging in Multiple Species.

Authors:  Alessandro Bitto; Adrienne M Wang; Christopher F Bennett; Matt Kaeberlein
Journal:  Cold Spring Harb Perspect Med       Date:  2015-11-02       Impact factor: 6.915

5.  Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice.

Authors:  Roxanne Weiss; Elizabeth Fernandez; Yuhong Liu; Randy Strong; Adam B Salmon
Journal:  Aging (Albany NY)       Date:  2018-03-22       Impact factor: 5.682

Review 6.  Impact of Growth Hormone-Related Mutations on Mammalian Aging.

Authors:  Andrzej Bartke; Nana Quainoo
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 7.  Insulin-like growth factor-1 deficiency and metabolic syndrome.

Authors:  G A Aguirre; J Rodríguez De Ita; R G de la Garza; I Castilla-Cortazar
Journal:  J Transl Med       Date:  2016-01-06       Impact factor: 5.531

8.  Association between exonic polymorphism (rs629849, Gly1619Arg) of IGF2R gene and obesity in Korean population.

Authors:  Seung-Ae Yang
Journal:  J Exerc Rehabil       Date:  2015-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.